---
figid: PMC7064362__jbm-27-53-g005
figlink: pmc/articles/PMC7064362/figure/F5/
number: Fig. 5
caption: . Schematic diagram of the effect of Rosae Multiflorae fructus extract (RMF-E)
  on receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis.
  The RANKL/RANK interaction may lead to mitogen-activated protein kinases (MAPKs)
  activation, followed by induction of c-Fos expression, and it also leads to Bruton's
  tyrosine kinase (BTK) and phospholipase C-γ2 (PLCγ2) activation inducing calcium
  signaling, followed by induction of nuclear factor-activated T cells c1 (NFATc1)
  expression and activation. RMF-E may inhibit NFATc1 induction via suppression of
  c-Fos and modulation of the BTK/PLCγ signaling pathways regulating Ca2+ signaling,
  resulting in the inhibition of RANKL-induced osteoclastogenesis. The red line indicates
  the inhibition pathway of RMF-E. TRAF6, tumor necrosis factor receptor associated
  factor 6; ITAM, immunoreceptor tyrosine-based activation motif.
pmcid: PMC7064362
papertitle: Inhibitory Effect of Rosae Multiflorae Fructus Extracts on the Receptor
  Activator of NF-κB Ligand-Induced Osteoclastogenesis through Modulation of P38-
  and Ca2+-Mediated Nuclear Factor of Activated T-Cells Cytoplasmic 1 Expression.
reftext: Keun Ha Park, et al. J Bone Metab. 2020 Feb;27(1):53-63.
pmc_ranked_result_index: '69009'
pathway_score: 0.9557148
filename: jbm-27-53-g005.jpg
figtitle: Inhibitory Effect of Rosae Multiflorae Fructus Extracts on the Receptor
  Activator of NFKB Ligand-Induced Osteoclastogenesis through Modulation of P38- and
  Ca2+-Mediated Nuclear Factor of Activated T-Cells Cytoplasmic 1 Expression
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7064362__jbm-27-53-g005.html
  '@type': Dataset
  description: . Schematic diagram of the effect of Rosae Multiflorae fructus extract
    (RMF-E) on receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis.
    The RANKL/RANK interaction may lead to mitogen-activated protein kinases (MAPKs)
    activation, followed by induction of c-Fos expression, and it also leads to Bruton's
    tyrosine kinase (BTK) and phospholipase C-γ2 (PLCγ2) activation inducing calcium
    signaling, followed by induction of nuclear factor-activated T cells c1 (NFATc1)
    expression and activation. RMF-E may inhibit NFATc1 induction via suppression
    of c-Fos and modulation of the BTK/PLCγ signaling pathways regulating Ca2+ signaling,
    resulting in the inhibition of RANKL-induced osteoclastogenesis. The red line
    indicates the inhibition pathway of RMF-E. TRAF6, tumor necrosis factor receptor
    associated factor 6; ITAM, immunoreceptor tyrosine-based activation motif.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF11A
  - SYK
  - TRAF6
  - BTK
  - TEC
  - LCP2
  - BLNK
  - MAPK14
  - MAPK11
  - MAPK13
  - MAPK12
  - PLCG1
  - PLCG2
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - FOS
  - PPP3R2
  - PPP3CA
  - PPP3CB
  - PPP3CC
  - PPP3R1
  - NFATC1
  - Ca2+
genes:
- word: RANK
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
- word: Syk
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: Btk/Tec
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: Btk/Tec
  symbol: TEC
  source: hgnc_symbol
  hgnc_symbol: TEC
  entrez: '7006'
- word: BLNK/SLP76
  symbol: SLP76
  source: hgnc_prev_symbol
  hgnc_symbol: LCP2
  entrez: '3937'
- word: BLNK/SLP76
  symbol: BLNK
  source: hgnc_symbol
  hgnc_symbol: BLNK
  entrez: '29760'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: с-Fos
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: NFATC1
  symbol: NFATC1
  source: hgnc_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
chemicals:
- word: Ca2+
  source: MESH
  identifier: D002118
diseases: []
---
